ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "Systemic JIA and rituximab"

  • Abstract Number: 2170 • ACR/ARHP Annual Meeting 2013

    Efficacy and Safety Of Long-Term Rituximab Use In Patients With Systemic Juvenile Idiopathic Arthritis: The Results Of 5-Year Follow-Up In Real Clinical Practice

    Ekaterina Alexeeva1,2, Alexander Baranov2,3, Saniya Valieva1, Tatyana Bzarova1, Rina Denisova1, Kseniya Isayeva1, Tatyana Sleptsova1, Elena Mitenko1, Evgeniya Chistyakova1,2, Anna Fetisova1, Elena Semikina4 and Svetlana Akulova1, 1Rheumatology, Scientific Center of Children's Health of RAMS, Moscow, Russia, 2I.M.Sechenov First Moscow State Medical University, Moscow, Russia, 3Scientific Center of Children's Health of RAMS, Moscow, Russia, 4Clinical Laboratory, Scientific Center of Children's Health of RAMS, Moscw, Russia

    Background/Purpose: To assess the efficacy and safety of rituximab (RT) treatment in long-term follow-up of children with systemic juvenile idiopathic arthritis (sJIA). Methods: The results…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology